14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Arbutus Biopharma Corporation Stock Forecast

NASDAQ:ABUS BUY SELL

$2.40 (-1.64%)

Volume: 869.96k

Closed: May 23, 2022

Hollow Logo Score: -0.841

Arbutus Biopharma Corporation Stock Forecast

BUY SELL NASDAQ:ABUS
$2.40 (-1.64%)

Volume: 869.96k

Closed: May 23, 2022

Score Hollow Logo -0.841

Arbutus Biopharma Corporation Stock Forecast NASDAQ:ABUS

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-03-14 254.17% HC Wainwright & Co. $8.00 $8.50 Maintains Buy
2022-03-04 150% Chardan Capital $5.50 $6.00 Maintains Buy
2022-02-02 108.33% Jefferies $4.00 $5.00 Upgrades Hold Buy
2021-11-08 275% JMP Securities $7.00 $9.00 Maintains Market Outperform
2020-12-17 316.67% HC Wainwright & Co. $10.00 Initiates Coverage On Buy
2020-07-24 - Baird - Downgrades Outperform Neutral
2020-05-19 66.67% Wedbush $2.00 $4.00 Upgrades Neutral Outperform
2020-03-27 66.67% Baird $8.00 $4.00 Maintains Outperform
2020-03-06 108.33% Chardan Capital $1.50 $5.00 Upgrades Neutral Buy
2020-02-20 233.33% Baird $8.00 Initiates Coverage On Outperform
2020-02-05 316.67% JMP Securities $10.00 Upgrades Market Perform Market Outperform
2020-01-09 150% B. Riley Securities $3.00 $6.00 Maintains Buy
2019-10-04 - Chardan Capital - Downgrades Buy Neutral

ABUS Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -26.80% during the next 3 months and, with a 90% probability hold a price between $1.35 and $1.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-25 $1.82 $2.22 $2.62
2022-05-26 $1.81 $2.20 $2.60
2022-05-27 $1.79 $2.19 $2.59
2022-05-31 $1.77 $2.17 $2.57
2022-06-01 $1.76 $2.16 $2.55
2022-06-02 $1.74 $2.14 $2.54
2022-06-03 $1.73 $2.12 $2.52
2022-06-06 $1.71 $2.11 $2.51
2022-06-07 $1.70 $2.09 $2.49
2022-06-08 $1.68 $2.08 $2.47
2022-06-09 $1.66 $2.06 $2.46
2022-06-10 $1.65 $2.05 $2.44
2022-06-13 $1.63 $2.03 $2.43
2022-06-14 $1.62 $2.01 $2.41
2022-06-15 $1.60 $2.00 $2.40
2022-06-16 $1.58 $1.98 $2.38
2022-06-17 $1.57 $1.97 $2.36
2022-06-21 $1.55 $1.95 $2.35
2022-06-22 $1.54 $1.93 $2.33
2022-06-23 $1.52 $1.92 $2.32
2022-06-24 $1.51 $1.90 $2.30
2022-06-27 $1.49 $1.89 $2.29
2022-06-28 $1.47 $1.87 $2.27
2022-06-29 $1.46 $1.86 $2.25
2022-06-30 $1.44 $1.84 $2.24
2022-07-01 $1.43 $1.82 $2.22
2022-07-05 $1.41 $1.81 $2.21
2022-07-06 $1.40 $1.79 $2.19
2022-07-07 $1.38 $1.78 $2.17
2022-07-08 $1.36 $1.76 $2.16

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). Its lead candidate is ARB-1467, a multi-component RNAi therapeutic product that is designed for the elimination of HBV surface antigen expression in patients chronically i... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT